Cassava Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $840 | $0 | $0 | $1,222 |
Gross Profit | -200 | -5,116 | -13,666 | -20,530 |
EBITDA | -10,607 | -13,874 | -21,366 | -19,327 |
EBIT | -10,807 | -14,092 | -21,586 | -19,587 |
Net Income | -10,807 | -44,224 | -23,403 | -27,597 |
Net Change In Cash | 840 | 0 | 0 | 1,222 |
Free Cash Flow | -6,301 | -4,947 | -11,336 | -61,322 |
Cash | 106,080 | 112,381 | 117,328 | 128,574 |
Basic Shares | 48,293 | 48,308 | 48,262 | 48,099 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-1 | $0 |
Gross Profit | -1,132 | -89,423 | -1 | -534 |
EBITDA | -141,146 | -104,427 | -78,719 | -32,334 |
EBIT | -142,278 | -105,957 | -80,020 | -32,868 |
Net Income | -24,342 | -97,217 | -72,472 | -31,802 |
Net Change In Cash | 0 | 0 | -1 | 0 |
Cost of Revenue | 139,931 | |||
Free Cash Flow | -117,032 | -82,439 | -80,226 | -52,410 |
Cash | 128,574 | 121,136 | 201,015 | 233,437 |
Basic Shares | 46,604 | 41,932 | 40,202 | 39,405 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.22 |
2025-06-30 | -$0.92 |
2025-03-31 | -$0.48 |
2024-12-31 | -$0.57 |
